# DESCRIPTION

## CROSS REFERENCE

- claim priority to provisional patent application

## FIELD OF THE INVENTION

- relate to GAB1 inhibitors and cancer treatment

## BACKGROUND OF THE INVENTION

- motivate GAB1 overexpression in cancer
- describe GAB1 structure and function
- discuss limitations of current cancer treatments

## SUMMARY OF THE INVENTION

- summarize GAB1 PH domain inhibitors for cancer treatment

## DESCRIPTION OF PREFERRED EMBODIMENTS

- define alkyl
- define alkenyl and alkynyl
- define alkoxy and aryl
- define heterocycle and heteroaryl
- define cycloalkyl and cycloalkenyl
- define various other terms and phrases
- define key terms
- describe pharmaceutical composition
- introduce compounds and their structures
- outline methods of treatment and administration
- describe virtual screening and protein structure prediction
- retrieve protein sequence
- predict secondary structure and perform homology modeling
- perform virtual screening and pharmacophore modeling
- refine 3D structure of GAB1/IRS1 PH domain in complex with inhibitors
- calculate PMF-based binding free energy
- perform surface plasmon resonance spectroscopy binding assays
- perform cellular proliferation assay and inhibition of GAB1 and IRS1 phosphorylation
- introduce PH domains
- describe fold recognition and sequence alignment
- generate PSSMs for Î²-sheets
- predict secondary structure of GAB1 PH domain
- perform homology modeling and molecular dynamics
- identify novel inhibitors using virtual screening
- evaluate bioactivities of identified hits
- perform MD simulation of protein-ligand complexes
- calculate absolute binding free energies
- describe ligand-induced conformational changes of PH domain

